Brief

Cutting-edge design that puts the patient first is at the heart of a new drug delivery device for multiple sclerosis (MS) sufferers.

We worked with leading pharmaceutical company Novartis and medical device manufacturer Owen Mumford – plus hundreds of MS patients – to come up with the ExtaviPro® 30G auto-injector.

Approach

Our aim was to make the ExtaviPro 30G auto-injector very simple and intuitive to use, and enable one-handed injection.

Its ergonomic shape leads patients to instinctively hold it correctly – which is vital for those who suffer from tremors, as having a firm grip is key to self-injecting safely. Patients also wanted a soft, non-threatening design, for example – so we’ve made it very user friendly.

Our team also developed the accompanying instruction leaflets as well as the travel bag for carrying the device and supplies for injections. The bag went through several rounds of user studies to ensure it best suited individual lifestyles.

Benefit

From its attractive visual design and ergonomic shape to its easy-to-read adjustable needle depth control, the ExtaviPro 30G has been designed with the needs of the patient in mind.

More than 500 MS patients and healthcare professionals in the US, the UK and mainland Europe were involved in the development process to ensure the device was underpinned by a deep understanding of the users.

The ExtaviPro 30G auto-injector has been launched in Europe – initially in Germany.